ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 148

Lack of Screening By Rheumatologists and Primary Care Physicians for Childhood Sexual Abuse in Patients with Fibromyalgia-Depression Overlap: An Unrecognized Crisis?

M. Anthony Albornoz1, Christian Albornoz2 and Daniel J. Clauw3, 1Rheumatology, Riddle Memorial Hospital/Mainline Health System, Media, PA, 2Temple University School of Medicine, Philadelphia, PA, 3Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Anxiety, depression and fibromyalgia, Sexuality

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression is reported in as many as 71% of patients with Fibromyalgia (FM). An association between Childhood Sexual Abuse (CSA) and FM has been well documented and is responsible for inducing disturbing levels of chronic physical and psycho-affective morbidity. Based on the 28-year experience of the lead author, the frequency of CSA in patients with Fibromyalgia-Depression Overlap (FDO) is thought to be highly underestimated, principally due to the underutilization of validated screening questions by Rheumatologists (RH), Internists and Family Medicine Physicians (PCP). We primarily sought to determine the frequency of CSA screening by RH and PCP in patients with FDO and the incidence of CSA in new patients with FDO. Additional clinical and psychosocial variables were secondarily assessed.

Methods: A retrospective analysis conducted over a 12 month period in an outpatient, community-based, solo private practice setting of 131 consecutive new adult patients diagnosed with FM by one RH. All patients were screened for depression, anxiety and CSA using validated tools(PHQ-9, GAD-7,Gen Hosp Psychiatry. 2007 Jan-Feb;29(1):8-13) . CSA patients were asked whether past and/or present PCP and past RH inquired about CSA. All patients met the 2010 ACR criteria for FM.

Results: All data is summarized in Table. Noteworthy clinical findings included: Of the 131 FM patients, 100% were female, 82 (63%) were diagnosed with FDO and 18 (22%) of FDO patients revealed they were victims of CSA; CSA was not encountered in the non-FDO population; CSA mean age was 42 with an age range of 18-74; mean age at time of abuse 13; oldest age when CSA first divulged was 74; 16 (89%) of CSA patients were under age 65 and of these 13 (81%) were either on disability or unemployed; 6 (33%) family member(‘s) did not believe claim of CSA; 14 (78%) of CSA patients requested that abuse history not be included in the medical record; 11 (61%) of assailants were 1st degree relatives; CSA patients never queried by physicians about sexual abuse: active and/or past PCP 15 (83%) and past RH 9 (100 %); Psychiatric/Psychological care given in 18 (100%) of CSA patients; 18 (100%) of CSA patients experienced past suicidal ideations and 11 (61%) active suicidal ideations; 8 (44 %) attempted suicide; 18 (100%) had active depression and 16 (89%) had active anxiety; 15 (83%) active severe depression; 14 (78%) active severe anxiety; 16 (89%) active panic attacks.

Conclusion: The structure and small sample size of this investigation limits our ability to draw definitive conclusions. However, these data reveal that in an alarmingly high number of FDO patients previously evaluated by RH and PCP, CSA escaped detection. The results of this analysis highlights that patients with FDO-CSA likely represent a particularly at-risk population who are in need of greater physician awareness and a more focused assessment. A multi-state study addressing this topic is in progress.


Disclosure: M. A. Albornoz, None; C. Albornoz, None; D. J. Clauw, Abbott Pharmaceutical, 5,Aptinyx, 5,Astellas Phamaceutical, 5,Cerephex, 5,Daiichi Sankyo, 5,Pfizer Inc, 5,Pierre Fabre, 8,Samumed, 5,Theravance, 5,Tonix, 5.

To cite this abstract in AMA style:

Albornoz MA, Albornoz C, Clauw DJ. Lack of Screening By Rheumatologists and Primary Care Physicians for Childhood Sexual Abuse in Patients with Fibromyalgia-Depression Overlap: An Unrecognized Crisis? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/lack-of-screening-by-rheumatologists-and-primary-care-physicians-for-childhood-sexual-abuse-in-patients-with-fibromyalgia-depression-overlap-an-unrecognized-crisis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lack-of-screening-by-rheumatologists-and-primary-care-physicians-for-childhood-sexual-abuse-in-patients-with-fibromyalgia-depression-overlap-an-unrecognized-crisis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology